ML14024A442: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
 
(Created page by program invented by StriderTol)
Line 13: Line 13:
| page count = 2
| page count = 2
}}
}}
=Text=
{{#Wiki_filter:CENG.a joint venture ofConstellation 1619. Energy0 .* -,,eDFNINE MILE POINTNUCLEAR STATIONJanuary 7, 2014U.S. Nuclear Regulatory Commission Washington, DC 20555-0001 ATTENTION:
==SUBJECT:==
Document Control DeskNine Mile Point Nuclear Station, Units 1 and 2Renewed Facility Operating License Nos. DPR-63 and NPF-69Docket Nos. 50-220 and 50-4 10Submittal of Report in Accordance with 10 CFR 26.719(c)(1)
==REFERENCE:==
(1) Letter from K. J. Clark (NMPNS) to Document Control (NRC), datedNovember 14, 2013, Nine Mile Point Nuclear Station, Units 1 and 2,Submittal of Report in Accordance with 10 CFR 26.719(c)(1)
In accordance with 10 CFR 26.719(c)(1),
Nine Mile Point Nuclear Station, LLC (NMPNS) is submitting the following report regarding unsatisfactory blind performance sample testing:Description of IncidentOn November 14, 2013, an amphetamine positive sample was prepared for submittal from NMPNS to aHealth and Human Services (HHS)-Laboratory (Quest-Norristown) for blind performance
: testing, inaccordance with 10 CFR 26.168. The sample's manufactured date was July 15, 2013, shipped toNMPNS in October and was noted to expire on January 15, 2014. Results of the sample analyzed by theHI-HIS-laboratory, reported to NMPNS on November 19, 2013, indicated an Invalid test, as well as positivefor amphetamines.
The HHS-laboratory recognized the sample met the criteria for positive;
: however, thesample also met the criteria for Invalid, in accordance with 10 CFR 26.161(0(1).
This was due to thecreatinine of the sample was measured by two (2) different meters at the HI-IS-laboratory which indicated similar readings of approximately 1.0 and 1.3 (which were less than 2 and the specific gravity wasgreater than 1.0010 but less than 1.0200).
The Blind Sample provider (Professional Toxicology) provided documentation that the sample was designed to meet only the positive criteria.
Nine Mile Point Nuclear Station, LLCP.O. Box 63, Lycoming, NY 13093 Document Control DeskJanuary 7, 2014Page 2This is very similar to a NMPNS blind sample issue reported to the NRC in Reference (1).Corrective Actions Taken or PlannedIn addition to contacting the HHS Laboratory and the Blind Sample Provider, NMPNS contacted industrycounterparts to determine if any other utility experienced similar issues related to blind sampleperformance testing.
The benchmark revealed that three (3) other utilities experienced the same issuewith the same lot number. The blind sample provider did not offer any undisputable reasons for theissues, but did suggest that the issues could have been caused from the bleach wash of their containers orone of the drug-free donor's recent change in diet supplements.
Another provider will be procured for 2014.Should you have any questions regarding the information in this submittal, please contact Everett P.Perkins, Director
-Licensing, at (315) 349-5219.
Very truly yKevin J. ClarkDirector, SecurityKJC/MHScc: NRC Regional Administrator, Region INRC Project ManagerNRC Senior Resident Inspector}}

Revision as of 01:19, 3 July 2018

Nine Mile Point, Units 1 and 2 - Submittal of Report in Accordance with 10 CFR 26.719(c)(1) Regarding Unsatisfactory Blind Performance Sample Testing
ML14024A442
Person / Time
Site: Nine Mile Point  Constellation icon.png
Issue date: 01/07/2014
From: Clark K J
Constellation Energy Nuclear Group, EDF Group, Nine Mile Point
To:
Document Control Desk, Office of Nuclear Reactor Regulation
References
Download: ML14024A442 (2)


Text

CENG.a joint venture ofConstellation 1619. Energy0 .* -,,eDFNINE MILE POINTNUCLEAR STATIONJanuary 7, 2014U.S. Nuclear Regulatory Commission Washington, DC 20555-0001 ATTENTION:

SUBJECT:

Document Control DeskNine Mile Point Nuclear Station, Units 1 and 2Renewed Facility Operating License Nos. DPR-63 and NPF-69Docket Nos. 50-220 and 50-4 10Submittal of Report in Accordance with 10 CFR 26.719(c)(1)

REFERENCE:

(1) Letter from K. J. Clark (NMPNS) to Document Control (NRC), datedNovember 14, 2013, Nine Mile Point Nuclear Station, Units 1 and 2,Submittal of Report in Accordance with 10 CFR 26.719(c)(1)

In accordance with 10 CFR 26.719(c)(1),

Nine Mile Point Nuclear Station, LLC (NMPNS) is submitting the following report regarding unsatisfactory blind performance sample testing:Description of IncidentOn November 14, 2013, an amphetamine positive sample was prepared for submittal from NMPNS to aHealth and Human Services (HHS)-Laboratory (Quest-Norristown) for blind performance

testing, inaccordance with 10 CFR 26.168. The sample's manufactured date was July 15, 2013, shipped toNMPNS in October and was noted to expire on January 15, 2014. Results of the sample analyzed by theHI-HIS-laboratory, reported to NMPNS on November 19, 2013, indicated an Invalid test, as well as positivefor amphetamines.

The HHS-laboratory recognized the sample met the criteria for positive;

however, thesample also met the criteria for Invalid, in accordance with 10 CFR 26.161(0(1).

This was due to thecreatinine of the sample was measured by two (2) different meters at the HI-IS-laboratory which indicated similar readings of approximately 1.0 and 1.3 (which were less than 2 and the specific gravity wasgreater than 1.0010 but less than 1.0200).

The Blind Sample provider (Professional Toxicology) provided documentation that the sample was designed to meet only the positive criteria.

Nine Mile Point Nuclear Station, LLCP.O. Box 63, Lycoming, NY 13093 Document Control DeskJanuary 7, 2014Page 2This is very similar to a NMPNS blind sample issue reported to the NRC in Reference (1).Corrective Actions Taken or PlannedIn addition to contacting the HHS Laboratory and the Blind Sample Provider, NMPNS contacted industrycounterparts to determine if any other utility experienced similar issues related to blind sampleperformance testing.

The benchmark revealed that three (3) other utilities experienced the same issuewith the same lot number. The blind sample provider did not offer any undisputable reasons for theissues, but did suggest that the issues could have been caused from the bleach wash of their containers orone of the drug-free donor's recent change in diet supplements.

Another provider will be procured for 2014.Should you have any questions regarding the information in this submittal, please contact Everett P.Perkins, Director

-Licensing, at (315) 349-5219.

Very truly yKevin J. ClarkDirector, SecurityKJC/MHScc: NRC Regional Administrator, Region INRC Project ManagerNRC Senior Resident Inspector